---
schema_version: "secwatch.filing_event.v1"
accession: "0000896262-24-000018"
form_type: "8-K"
ticker: null
cik: "0000896262"
company_name: "AMEDISYS INC"
filed_at: "2024-04-24T23:59:59+00:00"
generated_at: "2026-06-03T10:56:28.769050+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Amedisys Q1 revenue up to $571.4M; adjusted EPS $1.03 vs $1.00 YoY

## Summary
- Net service revenue $571.4M, up $15.0M YoY; prior year included $15M from divested personal care.
- GAAP net income $14.4M ($0.44 diluted EPS) vs $25.2M ($0.77) in 2023; includes $20.7M merger expenses.
- Adjusted EBITDA $59.9M vs $57.8M; adjusted net income $33.9M ($1.03 diluted EPS) vs $32.7M ($1.00).

## SEC filing metadata
- accession: 0000896262-24-000018
- form_type: 8-K
- cik: 0000896262
- company_name: AMEDISYS INC
- filed_at: 2024-04-24T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896262/000089626224000018/0000896262-24-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896262/000089626224000018/amed-20240424.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000896262-24-000018
- JSON: https://secwatch.observer/filing/0000896262-24-000018.json
- Plain text: https://secwatch.observer/filing/0000896262-24-000018.txt

## Key facts
- Earnings Releases
  AMEDISYS INC reported three-month period ended March 31, 2024 results: revenue Net service revenue increased $15.0 million to $571.4 million compared to $556.4 million in 2023., net income Net income attributable to Amedisys, Inc. of $14.4 million, EPS Net income attributable to Amedisys, Inc. per diluted share of $0.44 compared to $0.77 in 2023..
  - Period: three-month period ended March 31, 2024
  - Revenue: Net service revenue increased $15.0 million to $571.4 million compared to $556.4 million in 2023.
  - Net income: Net income attributable to Amedisys, Inc. of $14.4 million
  - EPS: Net income attributable to Amedisys, Inc. per diluted share of $0.44 compared to $0.77 in 2023.
  - Result: reported results
  source text: On April 24, 2024, Amedisys, Inc. ("we," "us," "our," or "the Company") issued a press release (the “Press Release”) announcing its financial results for the three-month period ended March 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/896262/000089626224000018/0000896262-24-000018-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.